"The xCELLigence RTCA SP analysis is without any doubts a proven non-invasive and sensitive method for monitoring the viability, proliferation or migration of cells in real time and thus complements and explains a number of end-point experiments. Our laboratory deals with the study of new natural molecules or compounds prepared semisynthetically. The analysis software is also intuitive and complete, moreover, ACCELA as a local supplier is able to provide qualified training and service."

XCelligence system represents very usefull and user friendly tool for monitoring of cell proliferation and migration under different treatment and conditions.

„Our researches are mostly focused in the context of type II Diabetes, Obesity and a broad range of applications in cell biolabeling, cancer treatment, metastasis and therapeutic drug monitoring. Compared to traditonal end-point method, xCelligence system revolutionized our workflow adding real-time monitoring of cells inside incubator as an fundamental factor to assess long term effect of different compounds of interest."

"xCelligence system offers unique technology that can be easily employed to measure and quantify the efficacy of cell-based immunotherapies. Indeed, we have successfully implemented protocols that enable us to monitor the efficacy of CAR T mediated cytotoxicity toward adherent breast cancer cells. The greatest advantage of the system is the real-time instead of the end-point readout. The data collected using the RTCA system fill in a common gap concerning the kinetics of the cell-based cytotoxicity process."    

“We successfully employed xCELLigence system for studying migration of malignant melanoma cell lines in response to variety of agents. We were also able to employ this system to measure the invasion of HUVEC endothelial cell monolayer by melanoma cells according to this:  JOVE protocol”